Experimental conditions that enhance potency of an antibacterial oligo-acyl-lysyl

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 6, 2010, Pages 2590-2595

  Goldfeder, Yair ^a   Zaknoon, Fadia ^a   Mor, Amram ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGO ACYL LYSYL DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IONIC STRENGTH; LISTERIA MONOCYTOGENES; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PH; PHOSPHOLIPID MEMBRANE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; TEMPERATURE;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; DRUG DESIGN; ESCHERICHIA COLI; HYDROGEN-ION CONCENTRATION; LISTERIA MONOCYTOGENES; MICROBIAL SENSITIVITY TESTS; MOLECULAR MIMICRY; OLIGOPEPTIDES; OSMOLAR CONCENTRATION; STAPHYLOCOCCUS AUREUS; STRUCTURE-ACTIVITY RELATIONSHIP; TEMPERATURE;

EID: 77952597321     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01656-09     Document Type: Article

References (60)

1. Abler, L., N. Klapes, B. Sheldon, and T. Klaenhammer. 1995. Inactivation of food-borne pathogens with magainin peptides. J. Food Prot. 58:381-388.
2. Bierne, H., and P. Cossart. 2007. Listeria monocytogenes surface proteins: from genome predictions to function. Microbiol. Mol. Biol. Rev. 71:377-397.
3. Reference deleted.
4. Boman, H. G., B. Agerberth, and A. Boman. 1993. Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infect. Immun. 61:2978-2984.
5. Reference deleted.
6. Bradshaw, J. 2003. Cationic antimicrobial peptides: issues for potential clinical use. BioDrugs 17:233-240. (Pubitemid 36999949)
7. Brogden, K. A. 2005. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3:238-250.
8. Choi, S., A. Isaacs, D. Clements, D. Liu, H. Kim, R. Scott, J. Winkler, and W. DeGrado. 2009. De novo design and in vivo activity of conformationally restrained antimicrobial arylamide foldamers. Proc. Natl. Acad. Sci. U. S. A. 106:6968.
9. Chongsiriwatana, N. P., J. A. Patch, A. M. Czyzewski, M. T. Dohm, A. Ivankin, D. Gidalevitz, R. N. Zuckermann, and A. E. Barron. 2008. Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides. Proc. Natl. Acad. Sci. U. S. A. 105:2794-2799.
10. Reference deleted.
11. Cudic, M., B. A. Condie, D. J. Weiner, E. S. Lysenko, Z. Q. Xiang, O. Insug, P. Bulet, and L. Otvos. 2002. Development of novel antibacterial peptides that kill resistant isolates. Peptides 23:2071-2083. (Pubitemid 36092040)
12. Diez-Gonzalez, F., and J. Russell. 1999. Factors affecting the extreme acid resistance of Escherichia coli O157: H7. Food Microbiol. 16:367-374.
13. Donnelly, J., L. Bellm, J. Epstein, S. Sonis, and R. Symonds. 2003. Antimicrobial therapy to prevent or treat oral mucositis. Lancet Infect. Dis. 3:405-412.
14. Reference deleted.
15. Epand, R. M., S. Rotem, A. Mor, B. Berno, and R. F. Epand. 2008. Bacterial membranes as predictors of antimicrobial potency. J. Am. Chem. Soc. 130: 14346-14352.
16. Epand, R. M., and H. J. Vogel. 1999. Diversity of antimicrobial peptides and their mechanisms of action. Biochim. Biophys. Acta 1462:11-28.
17. Fields, G. B., and R. L. Noble. 1990. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Pept. Protein Res. 35:161-214.
18. Fischer, W., and K. Leopold. 1999. Polar lipids of four Listeria species containing L-lysylcardiolipin, a novel lipid structure, and other unique phospholipids. Int. J. Syst. Bacteriol. 49:653-662.
19. Gaidukov, L., A. Fish, and A. Mor. 2003. Analysis of membrane-binding properties of dermaseptin analogues: relationships between binding and cytotoxicity. Biochemistry 42:12866-12874. (Pubitemid 37385817)
20. Galvez, A., H. Abriouel, R. L. Lopez, and O. N. Ben. 2007. Bacteriocin-based strategies for food biopreservation. Int. J. Food Microbiol. 120:51-70.
21. Gandhi, M., and M. L. Chikindas. 2007. Listeria: a foodborne pathogen that knows how to survive. Int. J. Food Microbiol. 113:1-15.
22. Gordon, Y., E. Romanowski, and A. McDermott. 2005. A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr. Eye Res. 30:505-515.
23. Reference deleted.
24. Hamon, M., H. Bierne, and P. Cossart. 2006. Listeria monocytogenes: a multifaceted model. Nat. Rev. Microbiol. 4:423-434.
25. Hancock, R. E., and H. G. Sahl. 2006. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24:1551-1557.
26. Held-Kuznetsov, V., S. Rotem, Y. Assaraf, and A. Mor. 2009. Host-defense peptide mimicry for novel antitumor agents. FASEB J. 23:4299-4307.
27. Humayun, M. Z. 1998. SOS and Mayday: multiple inducible mutagenic pathways in Escherichia coli. Mol. Microbiol. 30:905-910.
28. Lee, I. H., Y. Cho, and R. I. Lehrer. 1997. Effects of pH and salinity on the antimicrobial properties of clavanins. Infect. Immun. 65:2898-2903.
29. Lipsky, B., K. Holroyd, and M. Zasloff. 2008. Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double blinded, multicenter trial of pexiganan cream. Clin. Infect. Dis. 47:1537-1545.
30. Livne, L., T. Kovachi, H. Sarig, R. F. Epand, F. Zaknoon, R. M. Epand, and A. Mor. 2009. Design and characterization of a broad-spectrum bactericidal acyl-lysyl oligomer. Chem. Biol. 16:1250-1258.
31. Makobongo, M. O., T. Kovachi, H. Gancz, A. Mor, and D. S. Merrell. 2009. In vitro antibacterial activity of acyl-lysyl oligomers against Helicobacter pylori. Antimicrob. Agents Chemother. 53:4231-4239.
32. Mendoza, F., M. Maqueda, A. Galvez, M. Martinez-Bueno, and E. Valdivia. 1999. Antilisterial activity of peptide AS-48 and study of changes induced in the cell envelope properties of an AS-48-adapted strain of Listeria monocytogenes. Appl. Environ. Microbiol. 65:618-625.
33. Mor, A. 2009. Multifunctional host defense peptides: antiparasitic activities. FEBS J. 276:6474-6482.
34. Mowery, B. P., S. E. Lee, D. A. Kissounko, R. F. Epand, R. M. Epand, B. Weisblum, S. S. Stahl, and S. H. Gellman. 2007. Mimicry of antimicrobial host-defense peptides by random copolymers. J. Am. Chem. Soc. 129:15474-15476.
35. Mowery, B. P., A. H. Lindner, B. Weisblum, S. S. Stahl, and S. H. Gellman. 2009. Structure-activity relationships among random nylon-3 copolymers that mimic antibacterial host-defense peptides. J. Am. Chem. Soc. 131:9735-9745.
36. Perron, G. G., M. Zasloff, and G. Bell. 2006. Experimental evolution of resistance to an antimicrobial peptide. Proc. Biol. Sci. 273:251-256.
37. Radzishevsky, I., M. Krugliak, H. Ginsburg, and A. Mor. 2007. Antiplasmodial activity of lauryl-lysine oligomers. Antimicrob. Agents Chemother. 51: 1753-1759.
38. Radzishevsky, I. S., T. Kovachi, Y. Porat, L. Ziserman, F. Zaknoon, D. Danino, and A. Mor. 2008. Structure-activity relationships of antibacterial acyl-lysine oligomers. Chem. Biol. 15:354-362.
39. Radzishevsky, I. S., S. Rotem, D. Bourdetsky, S. Navon-Venezia, Y. Carmeli, and A. Mor. 2007. Improved antimicrobial peptides based on acyl-lysine oligomers. Nat. Biotechnol. 25:657-659.
40. Rasch, M. 2002. The influence of temperature, salt and pH on the inhibitory effect of reuterin on Escherichia coli. Int. J. Food Microbiol. 72:225-231.
41. Richard, H., and J. W. Foster. 2004. Escherichia coli glutamate- and arginine-dependent acid resistance systems increase internal pH and reverse transmembrane potential. J. Bacteriol. 186:6032-6041. (Pubitemid 39186991)
42. Rivas, L., J. Luque-Ortega, and D. Andreu. 2009. Amphibian antimicrobial peptides and Protozoa: lessons from parasites. Biochim. Biophys. Acta 1788: 1570-1581.
43. Rotem, S., and A. Mor. 2009. Antimicrobial peptide mimics for improved therapeutic properties. Biochim. Biophys. Acta 1788:1582-1592.
44. Rotem, S., I. S. Radzishevsky, D. Bourdetsky, S. Navon-Venezia, Y. Carmeli, and A. Mor. 2008. Analogous oligo-acyl-lysines with distinct antibacterial mechanisms. FASEB J. 22:2652-2661.
45. Reference deleted.
46. Rydlo, T., J. Miltz, and A. Mor. 2006. Eukaryotic antimicrobial peptides: promises and premises in food safety. J. Food Sci. 71:125.
47. Rydlo, T., S. Rotem, and A. Mor. 2006. Antibacterial properties of derma-septin S4 derivatives under extreme incubation conditions. Antimicrob. Agents Chemother. 50:490-497.
48. Sahl, H., U. Pag, S. Bonness, S. Wagner, N. Antcheva, and A. Tossi. 2005. Mammalian defensins: structures and mechanism of antibiotic activity. J. Leukoc. Biol. 77:466.
49. Sarig, H., L. Livne, V. Held-Kuznetsov, F. Zaknoon, A. Ivankin, D. Gidalevitz, and A. Mor. 2009. A miniature mimic of host defense peptides with systemic antibacterial efficacy. FASEB J. [Epub ahead of print.]
50. Sarig, H., S. Rotem, L. Ziserman, D. Danino, and A. Mor. 2008. Impact of self-assembly properties on antibacterial activity of short acyl-lysine oligomers. Antimicrob. Agents Chemother. 52:4308-4314.
51. Scott, R., W. DeGrado, and G. Tew. 2008. De novo designed synthetic mimics of antimicrobial peptides. Curr. Opin. Biotechnol. 19:620-627.
52. Seebach, D., and J. Gardiner. 2008. Beta-peptidic peptidomimetics. Acc. Chem. Res. 41:1366-1375.
53. Shah, N. H., G. L. Butterfoss, K. Nguyen, B. Yoo, R. Bonneau, D. L. Rabenstein, and K. Kirshenbaum. 2008. Oligo(N-aryl glycines): a new twist on structured peptoids. J. Am. Chem. Soc. 130:16622-16632.
54. Shai, Y. 2002. Mode of action of membrane active antimicrobial peptides. Biopolymers 66:236-248.
55. Tang, H., R. J. Doerksen, T. V. Jones, M. L. Klein, and G. N. Tew. 2006. Biomimetic facially amphiphilic antibacterial oligomers with conformationally stiff backbones. Chem. Biol. 13:427-435.
56. Verheul, A., N. J. Russell, T. H. R. Van, F. M. Rombouts, and T. Abee. 1997. Modifications of membrane phospholipid composition in nisin-resistant Listeria monocytogenes Scott A. Appl. Environ. Microbiol. 63:3451-3457.
57. Wu, G., J. Ding, H. Li, L. Li, R. Zhao, Z. Shen, X. Fan, and T. Xi. 2008. Effects of cations and pH on antimicrobial activity of thanatin and s-thanatin against Escherichia coli ATCC25922 and B. subtilis ATCC 21332. Curr. Microbiol. 57:552-557.
58. Yaron, S., T. Rydlo, D. Shachar, and A. Mor. 2003. Activity of dermaseptin K4-S4 against foodborne pathogens. Peptides 24:1815-1821. (Pubitemid 38198089)
59. Yeaman, M. R., and N. Y. Yount. 2003. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 55:27-55.
60. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-395.